223 related articles for article (PubMed ID: 12386459)
41. Cellular heterogeneity of CFTR expression and function in the lung: implications for gene therapy of cystic fibrosis.
Jiang Q; Engelhardt JF
Eur J Hum Genet; 1998 Jan; 6(1):12-31. PubMed ID: 9781011
[TBL] [Abstract][Full Text] [Related]
42. Inhibitory effect of cystic fibrosis sputum on adenovirus-mediated gene transfer in cultured epithelial cells.
Perricone MA; Rees DD; Sacks CR; Smith KA; Kaplan JM; St George JA
Hum Gene Ther; 2000 Sep; 11(14):1997-2008. PubMed ID: 11020799
[TBL] [Abstract][Full Text] [Related]
43. Terminal glycosylation in cystic fibrosis (CF): a review emphasizing the airway epithelial cell.
Rhim AD; Stoykova L; Glick MC; Scanlin TF
Glycoconj J; 2001 Sep; 18(9):649-59. PubMed ID: 12386452
[TBL] [Abstract][Full Text] [Related]
44. Self-complementary and tyrosine-mutant rAAV vectors enhance transduction in cystic fibrosis bronchial epithelial cells.
Lopes-Pacheco M; Kitoko JZ; Morales MM; Petrs-Silva H; Rocco PRM
Exp Cell Res; 2018 Nov; 372(2):99-107. PubMed ID: 30244179
[TBL] [Abstract][Full Text] [Related]
45. Novel molecular approaches to cystic fibrosis gene therapy.
Lee TW; Matthews DA; Blair GE
Biochem J; 2005 Apr; 387(Pt 1):1-15. PubMed ID: 15656784
[TBL] [Abstract][Full Text] [Related]
46. Adenovirus 5-fiber 35 chimeric vector mediates efficient apical correction of the cystic fibrosis transmembrane conductance regulator defect in cystic fibrosis primary airway epithelia.
Granio O; Ashbourne Excoffon KJ; Henning P; Melin P; Norez C; Gonzalez G; Karp PH; Magnusson MK; Habib N; Lindholm L; Becq F; Boulanger P; Zabner J; Hong SS
Hum Gene Ther; 2010 Mar; 21(3):251-69. PubMed ID: 19788389
[TBL] [Abstract][Full Text] [Related]
47. Prospects for virus-based gene therapy for cystic fibrosis.
Flotte TR
J Bioenerg Biomembr; 1993 Feb; 25(1):37-42. PubMed ID: 8382676
[TBL] [Abstract][Full Text] [Related]
48. Gene transfer to respiratory epithelial cells via the receptor-mediated endocytosis pathway.
Curiel DT; Agarwal S; Rømer MU; Wagner E; Cotten M; Birnstiel ML; Boucher RC
Am J Respir Cell Mol Biol; 1992 Mar; 6(3):247-52. PubMed ID: 1540389
[TBL] [Abstract][Full Text] [Related]
49. A phase I study of aerosolized administration of tgAAVCF to cystic fibrosis subjects with mild lung disease.
Aitken ML; Moss RB; Waltz DA; Dovey ME; Tonelli MR; McNamara SC; Gibson RL; Ramsey BW; Carter BJ; Reynolds TC
Hum Gene Ther; 2001 Oct; 12(15):1907-16. PubMed ID: 11589832
[TBL] [Abstract][Full Text] [Related]
50. Lactosylated polyethylenimine for gene transfer into airway epithelial cells: role of the sugar moiety in cell delivery and intracellular trafficking of the complexes.
Grosse S; Aron Y; Honoré I; Thévenot G; Danel C; Roche AC; Monsigny M; Fajac I
J Gene Med; 2004 Mar; 6(3):345-56. PubMed ID: 15026996
[TBL] [Abstract][Full Text] [Related]
51. Adeno-associated virus for cystic fibrosis gene therapy.
Martini SV; Rocco PR; Morales MM
Braz J Med Biol Res; 2011 Nov; 44(11):1097-104. PubMed ID: 21952739
[TBL] [Abstract][Full Text] [Related]
52. Bronchoalveolar fluid is not a major hindrance to virus-mediated gene therapy in cystic fibrosis.
Rooney CP; Denning GM; Davis BP; Flaherty DM; Chiorini JA; Zabner J
J Virol; 2002 Oct; 76(20):10437-43. PubMed ID: 12239320
[TBL] [Abstract][Full Text] [Related]
53. Safety and biological efficacy of an adeno-associated virus vector-cystic fibrosis transmembrane regulator (AAV-CFTR) in the cystic fibrosis maxillary sinus.
Wagner JA; Messner AH; Moran ML; Daifuku R; Kouyama K; Desch JK; Manley S; Norbash AM; Conrad CK; Friborg S; Reynolds T; Guggino WB; Moss RB; Carter BJ; Wine JJ; Flotte TR; Gardner P
Laryngoscope; 1999 Feb; 109(2 Pt 1):266-74. PubMed ID: 10890777
[TBL] [Abstract][Full Text] [Related]
54. Induction of a cAMP-stimulated chloride secretion in regenerating poorly differentiated airway epithelial cells by adenovirus-mediated CFTR gene transfer.
Dupuit F; Chinet T; Zahm JM; Pierrot D; Hinnrasky J; Kaplan H; Bonnet N; Puchelle E
Hum Gene Ther; 1997 Aug; 8(12):1439-50. PubMed ID: 9287144
[TBL] [Abstract][Full Text] [Related]
55. Physical and biological barriers to viral vector-mediated delivery of genes to the airway epithelium.
Pickles RJ
Proc Am Thorac Soc; 2004; 1(4):302-8. PubMed ID: 16113450
[TBL] [Abstract][Full Text] [Related]
56. Lentiviral vectors for gene therapy of cystic fibrosis.
Goldman MJ; Lee PS; Yang JS; Wilson JM
Hum Gene Ther; 1997 Dec; 8(18):2261-8. PubMed ID: 9449379
[TBL] [Abstract][Full Text] [Related]
57. Efficient gene transfer into human normal and cystic fibrosis tracheal gland serous cells with synthetic vectors.
Allo JC; Midoux P; Merten M; Souil E; Lipecka J; Figarella C; Monsigny M; Briand P; Fajac I
Am J Respir Cell Mol Biol; 2000 Feb; 22(2):166-75. PubMed ID: 10657937
[TBL] [Abstract][Full Text] [Related]
58. Non-viral vectors in cystic fibrosis gene therapy: recent developments and future prospects.
Pringle IA; Hyde SC; Gill DR
Expert Opin Biol Ther; 2009 Aug; 9(8):991-1003. PubMed ID: 19545217
[TBL] [Abstract][Full Text] [Related]
59. Cationic lipids for reporter gene and CFTR transfer to rat pulmonary epithelium.
Logan JJ; Bebok Z; Walker LC; Peng S; Felgner PL; Siegal GP; Frizzell RA; Dong J; Howard M; Matalon
Gene Ther; 1995 Jan; 2(1):38-49. PubMed ID: 7536114
[TBL] [Abstract][Full Text] [Related]
60. Nanocomplexes for gene therapy of respiratory diseases: Targeting and overcoming the mucus barrier.
Di Gioia S; Trapani A; Castellani S; Carbone A; Belgiovine G; Craparo EF; Puglisi G; Cavallaro G; Trapani G; Conese M
Pulm Pharmacol Ther; 2015 Oct; 34():8-24. PubMed ID: 26192479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
